References
- Arora S. K., Cho B. S., Venton D. L., Anderson R. J. A convenient single step preparation of dopamine-4-O-sulfate. Synthesis 1984; 884–885
- Baldwin M. K., Hutson D. H. The metabolism of 3-chloro-4-fluoroaniline in dog and rat. Xenobiotica 1980; 10: 135–144
- Capel I. D., French M. R., Millburn P., Smith R. L., Williams R. T. The fate of [14C]phenol in various species. Xenobiotica 1972; 2: 25–34
- Coldwell B. B., Thomas B. H., Whitehouse L. W., Wong L. T., Hynie I. Metabolism of 14C-acetoaminophen in humans and laboratory animals. Proceedings of the European Society of Toxicology 1976; 17: 269–276
- Eadsforth C. V., Coveney P. C., Hutson D. H., Logan C. J., Samuel A. J. The metabolism of o-fluoroaniline by rats, rabbits and marmosets. Xenobiotica 1986; 16: 555–566
- Hirom P. C., Millburn P., Smith R. L., Williams R. T. Species variations in the threshold molecular-weight factor for the biliary excretion of organic anions. Biochemical Journal 1972; 129: 1071–1077
- Hoffman K. J., Arfwidsson A., Borg K. O. The metabolic disposition of the selective β1-adrenoseptor agonist prenalterol in mice, rats, dogs and humans. Drug Metabolism and Disposition 1982; 10: 173–179
- Katayama S., Tsunoda H., Sakuma Y., Yoshimura T., Abe S. The effects of a novel 5-lipoxygenase inhibitor, E6080, on the bronchoconstrictions and leucotriene-mediated reactions in monkeys, guinea pigs and mice. XIVth Congress of the European Academy of Allergology and Clinical Immunology, Abstracts. Dustri-Verlag, Müncben-Deisenhofen 1989; 138
- Koster H., Halssma I., Schltens E., Knippers M., Mulder G. J. Dose-dependent shifts in the sulfation and glucuronidation of phenolic compounds in the rat in vivo and in isolated hepatocytes. Biochemical Pharmacology 1981; 30: 2569–2575
- Marten T. R., Bourne G. R., Miles G. S., Ranxine H. D., Dutka V. N. The metabolism of ICI 118,587, a partial agonist ofβ1-adrenoseptors, in mice, rats, rabbits, dogs and humans. Drug Metabolism and Disposition 1984; 12: 652–660
- Sakuma Y., Tsunoda H., Katayama S., Yoshimura T., Abe S. The effects of a new 5-lipoxygenase inhibitor, E6080, on a generation of leucotrienes from human, monkey and guinea pig lung fragments or inflammatory cells. XIVth Congress of the European Academy of Allergology and Clinical Immunology, Abstracts. Dustri-Verlag, München-Deisenhofen 1989; 139
- Samuelsson B. Leucotrienes: mediators of immediate hypersensirivity reactions and inflammation. Science 1983; 220: 568–575
- Simons P. J., Cockshott I. D., Douglas E. J., Gordon E. A., Hopkins K., Rowland M. Disposition in male volunteers of a subanaesthetic intravenous dose of an oil in water emulsion of 14C-propofol. Xenobiotica 1988; 18: 429–440
- Smith R. L., Timbrell J. A. Factors affecting the metabolism of phenacetin I. Influence of dose, chronic dosage, route of administration and species on the metabolism of [1-14C-Acetyl]phenacetin. Xenobiotica 1974; 4: 489–501
- Tsunoda H., Katayama S., Sakuma Y., Tsukidate K., Abe S., Tanaka S., Machida Y., Yamatsu I., Katayama K. Effect of a 5-liposygenase inhibitor, E6080, on leucotriene generation, and cell inflammation in the lung. American Review of Respiratory Disease 1989; 139: A140
- Welch R. M., Conney A. H., Burns J. J. Metabolism of acetoaminophen and N-acetyl-p-amino phenol in the cat. Biochemical Pharmacology 1966; 15: 521–531
- Williams R. T. Species variations in drug biotransformations. Fundamentals of Drug Metabolism and Drug Disposition, B. N. La Du, H. G. Mandel, E. L. Way. Williams and Wilkins, Baltimore 1971; 187–205